Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif

ArticleAçık Erişim

Özet

New Schiff base-bearing thiosemicarbazones (1–13) were obtained from 4-hydroxy-3,5-dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Density functional theory calculations were also performed to determine the spectroscopic properties of the compounds. Moreover, the enzyme inhibition activities of these compounds were investigated. They showed highly potent inhibition effects on acetylcholinesterase (AChE) and human carbonic anhydrases (hCAs) (KI values are in the range of 51.11 ± 6.01 to 278.10 ± 40.55 nM, 60.32 ± 9.78 to 300.00 ± 77.41 nM, and 64.21 ± 9.99 to 307.70 ± 61.35 nM for AChE, hCA I, and hCA II, respectively). In addition, molecular docking studies were performed, confirmed by binding affinities studies of the most potent derivatives. © 2022 Deutsche Pharmazeutische Gesellschaft.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12443Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1002/ardp.202200554Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDemir, Yeliz
dc.contributor.authorTürkeş, Cüneyt
dc.contributor.authorÇavuş, Muhammet S.
dc.contributor.authorErdoğan, Musa
dc.contributor.authorMuğlu, Halit
dc.contributor.authorYakan, Hasan
dc.contributor.authorBeydemir, Şükrü
dc.date.accessioned2026-10-18T20:27:20.665908131Z
dc.date.available2026-10-18T20:27:20.665908131Z
dc.date.issued2023
dc.description.abstractNew Schiff base-bearing thiosemicarbazones (1–13) were obtained from 4-hydroxy-3,5-dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Density functional theory calculations were also performed to determine the spectroscopic properties of the compounds. Moreover, the enzyme inhibition activities of these compounds were investigated. They showed highly potent inhibition effects on acetylcholinesterase (AChE) and human carbonic anhydrases (hCAs) (KI values are in the range of 51.11 ± 6.01 to 278.10 ± 40.55 nM, 60.32 ± 9.78 to 300.00 ± 77.41 nM, and 64.21 ± 9.99 to 307.70 ± 61.35 nM for AChE, hCA I, and hCA II, respectively). In addition, molecular docking studies were performed, confirmed by binding affinities studies of the most potent derivatives. © 2022 Deutsche Pharmazeutische Gesellschaft.
dc.description.sponsorshipFunding text 1: The author would like to thank the Research Fund of Anadolu University (grant number 2102S003). The DFT calculations reported in this paper were partially performed at TUBITAK ULAKBIM, High Performance and Grid Computing Center (TRUBA resources).; Funding text 2: The author would like to thank the Research Fund of Anadolu University (grant number 2102S003). The DFT calculations reported in this paper were partially performed at TUBITAK ULAKBIM, High Performance and Grid Computing Center (TRUBA resources).
dc.identifier.doi10.1002/ardp.202200554
dc.identifier.issn0365-6233
dc.identifier.issue4
dc.identifier.pmid36575148
dc.identifier.scopus2-s2.0-85145266945
dc.identifier.startpage2200554
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12443
dc.identifier.volume356
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofArchiv der Pharmazie
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDFT
dc.subjectenzyme inhibition
dc.subjectmolecular docking
dc.subjectspectroscopic elucidation
dc.subjectthiosemicarbazones
dc.subjectAcetylcholinesterase
dc.subjectBenzaldehydes
dc.subjectCarbonic Anhydrase I
dc.subjectCarbonic Anhydrase II
dc.subjectCarbonic Anhydrase Inhibitors
dc.subjectCholinesterase Inhibitors
dc.subjectDensity Functional Theory
dc.subjectHumans
dc.subjectMolecular Docking Simulation
dc.subjectMolecular Structure
dc.subjectStructure-Activity Relationship
dc.subject4 hydroxy 3,5 dimethoxy benzaldehyde
dc.subjectbenzaldehyde derivative
dc.subjectcarbonate dehydratase inhibitor
dc.subjectcholinesterase inhibitor
dc.subjectglyoxylic acid
dc.subjectisocyanic acid derivative
dc.subjectn (2 chlorophenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide
dc.subjectn (2 methoxyphenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide
dc.subjectn (3 chlorophenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide
dc.subjectn (3 methoxyphenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide
dc.subjectn (4 fluorophenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide
dc.subjectn (4 methylphenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide
dc.subjectn (4 nitrophenyl) 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide
dc.subjectn allyl 2 (4 hydroxy 3,5 dimethoxybenzylidene)hydrazine 1 carbothioamide
dc.titleEnzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus81
rdl.departmentDepartment of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexPUBMED